We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


16 May 2019 By Dasha Afanasieva

Nordic buyout group EQT will pay $10 bln for the Swiss giant’s dermal filler and acne cream business. At that price the acquirer will need plump growth assumptions to make an acceptable return. The smart disposal should help boss Mark Schneider keep activist Dan Loeb at bay.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)